While we're at it, here are a few more acquisitions that should happen right now.

Mylan's deal to buy Perrigo is taking another potential target off the block.

Teva, Actavis and other generics giants may start preying on each other.

With the recent deal for DAVA, Endo is now one of the best health care stocks to own.

These heavily shorted stocks could get squeezed on any positive catalyst.

Southwest employees are reportedly not happy about changes in the company's work culture.

Prime Medicine, a third-generation Crispr company, may test the choppy waters of the stock market with an IPO.

The e-commerce giant has just made a decision that suggests the health of the economy is not improving.

Well-known for his dislike of covid mandates, Elon Musk did not shy away from using the pandemic to reschedule his testimony.